BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and ...
CaaMTech's New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine DevelopersISSAQUAH, WA / ACCESSWIRE / November 14, 2024 / CaaMTech, Inc. is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback